INTRODUCTION
Numerous pathophysiological disorders have been demonstrated to be related to obesity. 1 Not exceptionally, accumulating evidence also suggests a role for obesity in the development of chronic kidney disease. 2 -4 The renal effects of obesity in humans and experimental animals include both functional and morphological adaptations, such as an increased glomerular filtration rate, increased renal blood flow, and renal hypertrophy with focal segmental glomerulosclerosis. 5 -7 Although the qualitative and quantitative information about the pathogenesis of the glomerulopathy associated with obesity remains to be delineated, varying degrees of metabolic abnormalities appear to be involved. Indeed, hyperinsulinemia resulted in the stimulation of the synthesis of insulin-like growth factors, and the upregulation of transforming growth factor-b1 by elevated serum leptin has been implicated in the chronic glomerulopathy associated with obesity. 8, 9 Moreover, hyperlipidemia may also promote glomerulosclerosis through mechanisms in which engagement of lipoprotein receptors on mesangial cells, oxidative cellular injury, macrophage chemotaxis and accelerated synthesis of fibrogenic cytokines are involved. 10 Interleukin (IL)-10 is a multifunctional cytokine with anti-inflammatory properties. 11 Accumulating evidence suggests potential roles for IL-10 in the management of several pathophysiological disorders, including obesity. Indeed, IL-10 has been shown to not only reduce cholesterol levels, but also to improve the insulin resistance in experimental animal models. 12, 13 Moreover, it has also been reported that obese patients and subjects with metabolic syndrome have a lower level of serum IL-10 than healthy normal subjects. 14 These observations led us to consider the therapeutic potential of modulating inflammation by IL-10 in the overall management of obese patients.
In the present study, we evaluated the effects of IL-10 on the renal characteristics of Zucker fatty (Zucker-fa/fa) rats, which have recently been focused on as an experimental animal model of renal injuries mediated by obesity-associated metabolic disorders. 7, 15, 16 The biological efficiency of the systemic administration of recombinant IL-10 seems to be insufficient because of the immediate decrease resulting from its short bioactive half-life. 17 Instead, we have transferred the gene encoding IL-10 using an adeno-associated virus (AAV) vector, as these vectors can be used to transduce skeletal muscle, thereby inducing the systemic and sustained expression of potentially therapeutic proteins following a single intramuscular administration. 12, 18 
RESULTS
The expression of IL-10 in Zucker rats Our first series of experiments verified the integrity of our vectors in the Zucker-fa/fa rats. The serum concentrations of IL-10 in the rats were determined at 5, 10, 15, 20 and 25 weeks after the initial treatments, which included the administration of phosphate buffer saline (PBS) and transductions of the recombinant AAV type 1-based vector carrying the rat IL-10 (AAV-IL-10) or control-enhanced green fluorescent protein gene (AAV-GFP). As shown in Figure 1 , statistically significant increases in serum IL-10 were confirmed in Zucker-fa/fa rats administered AAV-IL-10 (sham Zucker-fa/fa rats administered PBS (ZF)+IL-10), whereas the levels in Zucker-fa/fa rats administered AAV -GFP (ZF+GFP), ZF and control Zucker lean littermates (Zucker +/+) administered PBS (ZL) were comparable. The levels of IL-10 in ZF+IL-10 were about 12-fold higher at week 5, and an average of 5-fold higher than ZF, ZF+GFP and ZL groups at 25 weeks after the initial treatments.
The effects of IL-10 on clinical and laboratory characteristics The body weights of all rats were increased during the observation period. Although the degree of the increases was significantly higher in the Zucker-fa/fa rats than in the ZL rats, the mean body weights of ZF, ZF+GFP and ZF+IL-10 at each time point were comparable ( Figure 2a) . Similarly, the food consumption of the Zucker-fa/fa rats was significantly greater than that of the ZL, although there were no significant differences in the amount of food intake in the three Zucker-fa/fa rat groups (Figure 2b ). On the other hand, the serum levels of total cholesterol (Tcho) and triglycerides (TG) were significantly higher in Zucker-fa/fa rats compared with ZL throughout the observation period. However, in the ZF+IL-10, the serum Tcho was significantly lower than those in the ZF and ZF+GFP (Figure 2c ). Similar trends were also confirmed in the longitudinal changes in the serum TG. As shown in Figure 2d , Zucker-fa/fa rats had significantly higher serum TG than their lean littermates; however, the expression of IL-10 seemed to negatively affect the level of TG. At 30 weeks of age, these parameters negatively correlated with the IL-10 level in the Zucker-fa/fa rats with PBS or AAV treatment (Figures 2e and f) . During the observation period, no significant difference in the systolic blood pressure was observed in the Zucker-fa/fa rats treated with PBS or the AAV, although there was a trend for the systolic blood pressure in the ZL to be higher than that of all of the Zucker-fa/fa rats (data not shown).
We next analyzed the effect of IL-10 on the parameters related to the glucose metabolism. As shown in Table 1 , the fasting blood glucose levels of Zucker-fa/fa rats were significantly higher at 10 weeks after the administration of the vector with GFP or PBS administration compared with the lean littermates. At 30 weeks of age, we determined the blood hemoglobin A1c (HbA1c) and serum immuno-reactive insulin levels. As shown in Figure 3a , the transduction of IL-10 reversed the increase in the levels of HbA1c that was confirmed in ZF and ZF+GFP rats, thus suggesting that IL-10 might have a role in improving the disturbance of the fed-state glucose metabolism in the Zucker fa/fa rats. Indeed, the fed state serum insulin level was significantly elevated in ZF+IL-10 rats compared with the other groups, whereas the levels of fasting serum insulin in the Zucker-fa/ fa rats were comparable (Figure 3b ).
The effects of IL-10 on renal characteristics
We also explored the effects of IL-10 on the renal characteristics of the obese rats. As shown in Figure 4a , all three groups of obese rats (ZF, ZF+GFP and ZF+IL-10) demonstrated a gradual increase in urinary protein in a time-dependent manner, and the urinary protein level in the ZF and ZF+GFP finally increased up to 102.2±21.9 and 88.8 ± 30.0 mg per mgÁcreatinine, respectively. At 30 weeks of age, the urinary protein in the ZF+IL-10 (47.1 ± 11.6 mg per mgÁcreati-nine) was significantly lower than in the other Zucker-fa/fa rats groups (Po0.01). Moreover, the serum levels of IL-10 negatively correlated with the urinary protein level in Zucker-fa/fa rats (r¼À0.88, Po0.01, n¼17; Figure 4b ). During the observation period, the creatinine clearance (Ccr) in obese rats without IL-10 was significantly increased at both 25 and 30 weeks of age (Figure 4c ). There was also a negative correlation between the serum IL-10 level and Ccr (r¼À0.65, Po0.01, n¼15; Figure 4d ). Figure 5 shows the anatomical and morphological effects of IL-10 on the Zucker-fa/fa rats. All three groups of Zucker-fa/fa rats had significantly higher kidney weights than the ZL at 30 weeks of age. However, the expression of IL-10 caused a significant decrease in the kidney weight when compared with the ZF and ZF+GFP (1.70 ± 0.13 g versus 1.86±0.12 g, Po0.05, and 1.85±0.09 g, Po0.05, respectively; Figure 5a ). When viewed under a light microscope, there were no apparent histological changes compatible with glomerulosclerosis and cellular infiltrations within the glomerulus in any of the subjects; however, the Zucker-fa/fa rats had a larger area of glomeruli than the ZL, which was significantly reduced by the persistent expression of IL-10 in the ZF+IL-10 (Figures 5b and c). Transmission electron microscopy showed the hyperplastic glomerular basement membrane (GBM) and prominent foot process effacement in ZF and ZF+GFP (Figure 5b ), but these changes seemed to be prevented or reversed in the ZF+IL-10. Indeed, there were significant differences in the mean width of the GBM between the ZF+IL-10 and the other two groups of Zucker-fa/fa rats ( Figure 5d ). The lack of uniformity and regularity of the foot process demonstrated by scanning electron microscopic was remarkable in the ZF and ZF+GFP, but this was not observed in the ZF+IL-10 and ZL (Figure 5b ).
The effects of IL-10 on the expression of nephrin within the glomeruli of Zucker-fa/fa rats To determine the potential mechanisms of the counter-effect of IL-10 on the changes in the renal characteristics in the Zucker-fa/fa rats, we evaluated the effects of IL-10 on the expression of nephrin within glomeruli. As shown in Figure 6 , the glomerular nephrin expressions in Zucker fa/fa rats treated with PBS or AAV -GFP were significantly diminished compared with that of lean littermates, and the transduction of IL-10 apparently reversed the reduced expression of nephrin within glomeruli that was observed in the Zucker-fa/fa rats ( Figure 6 ). Interleukin 10 and obesity-related nephropathy M Ogura et al
DISCUSSION
The present study clearly demonstrates for the first time that IL-10, delivered by an AAV vector, suppresses the changes in renal characteristics in obese rats, including the increase in urinary protein, elevated Ccr, glomerular hypertrophy and the decreased glomerular expression of nephrin, without affecting the body weight and food intake of the rats. These results suggest the potential benefits of IL-10 in the management of obese subjects with renal pathophysiological abnormalities.
Numerous studies have focused on the abnormalities in lipid metabolism as a potential mechanism underlying various types of glomerular injuries, and the treatment of hyperlipidemia has been shown to reduce the excretion of urinary proteins and to decrease the Figure 2 The changes in the body weights (a), food consumption (b), serum Tcho (c) and serum TG (d). The body weights and food consumption were significantly higher in obese rats than in lean littermates at each point time. Note that the body weights and the food consumption in the three groups of obese rats were comparable, whereas the serum Tcho and TG levels were significantly lower than those in the ZF and ZF+GFP groups. The data are the means±s.d. (n¼6). **Po0.01 versus the control; # Po0.05, ## Po0.01 versus ZF and ZF+GFP groups. The relationships between IL-10 and Tcho (e) and TG (f) were also evaluated (groups: ZF, ZF+GFP and ZF+IL-10; n¼6 per group; r¼À0.77, Po0.01 and r¼À0.77, Po0.01, respectively). Figure 3 The effect of the IL-10 expression on the level of blood HbA1c (a) and serum immunoreactive insulin (b). The data were determined with blood samples obtained from rats at 30 weeks of age. **Po0.01 versus the control and ## Po0.01, respectively.
Interleukin 10 and obesity-related nephropathy M Ogura et al glomerular injury characterized by mesangial matrix expansion and focal segmental glomerulosclerosis, which are typical of Zucker fa/fa rats at about 60 weeks of age, without any changes in glomerular hemodynamic function. 7, 10, 16, 19 As such renal structural alterations seem to be relatively nonspecific and may represent part of a common final pathway, 15 we focused on the changes in renal characteristics that precede the development of mesangial matrix expansion and focal segmental glomerulosclerosis. Consistently, the histological analyses of our Zucker fa/fa rats performed at 30 weeks of age failed to demonstrate such glomerular lesions. Instead, glomerular hypertrophy, an increase in the widths of the GBM and the elevation of Ccr due to presumable glomerular hyperfiltration, which have all been implicated in hyperglycemia and are considered to be early events followed by diabetic glomerulosclerosis among diabetic subjects, 20 -22 were observed. These findings might not be surprising, as abnormal glucose metabolism characterized by mild hyperglycemia, as well as hyperinsulinemia and insulin resistance, are alternative metabolic characteristics of Zucker fa/fa rats. 7, 15, 23 Obviously, this was also the case with the present study. Of note, IL-10 seems to improve the disturbed fed-state glucose metabolism of the Zucker fa/fa rats, as the HbA1c in ZF-IL-10 rats was significantly decreased compared with the rest of the obese groups. The recovery from advanced insulin resistance is unlikely to be implicated in these rats. Instead, the accelerated increase in serum insulin seems to be involved in the countervailing effect of IL-10 on the glucose intolerance. Such an increase in serum insulin may be attributable to a change in the metabolic clearance or altered sensitivity to blood glucose. Alternatively, IL-10 might stimulate pancreatic b-cell function. 24 Although the elevation of serum insulin seemed to be necessary for glycemic control among our obese animals, one may argue that this might have adverse consequences on the renal tissue, and thus, might contribute to the development of a wide range of glomerular and interstitial injuries associated with disturbed glucose metabolism.
Indeed, it has been shown that hyperinsulinemia pleiotropically affects the kidney tissue through various pathways. 8, 9, 25 Nevertheless, renal pathophysiological evaluations failed to confirm the adverse effect of hyperinsulinemia in ZF-IL10 rats. Our results suggest that the biological significance of the improvement in glucose intolerance, mediated by the further increase in serum insulin induced by IL-10, on the renal characteristics of Zucker fa/fa rats should exceed that of hyperinsulinemia. Otherwise, an alternative process independent of the regulation of obesity-related metabolic disturbance might be involved in the countervailing effect of IL-10 on the renal pathophysiological characteristics among our obese animals.
Whether the glomerular morphological changes demonstrated in the present study cause or contribute to the presumable development of mesangial matrix expansion and focal segmental glomerulosclerosis in Zucker-fa/fa rats, which have been demonstrated to have abnormal lipid metabolism at ages older than 30 weeks, 7, 10, 16, 19 remains to be determined. However, the fact that there were significant decreases in the serum levels of Tcho and TG in the ZF+IL-10 rats led us to consider that the early phase of the changes in the renal characteristics of Zucker fa/fa rats might be modulated, at least in part, by IL-10 through the reduction of Tcho and TG. Although the course of the etiological linkage between IL-10 and TG remains to be delineated, previous data suggest that IL-10 might have a direct effect on the cholesterol metabolism through the suppression of the hydroxymethylglutaryl-CoA reductase expression, thereby lowering the Tcho level. 12 A hyperplastic GBM is often accompanied by changes in the visceral glomerular epithelial cells, that is, podocytes, and a progressive loss of podocyte foot processes associates with narrowing of the filtration slits, whereas the number of podocytes decreases with the increase in Interleukin 10 and obesity-related nephropathy M Ogura et al urinary protein excretion. 26, 27 Although the precise number of podocytes was not quantified in the present study, such pathogenic processes were likely modulated by IL-10, as the prominent foot process effacement associated with the hyperplastic GBM, and the lack of uniformity and regularity of the foot process confirmed in ZF and ZF-GFP were recovered in ZF+IL-10. Moreover, IL-10 remarkably blunted the reduced glomerular expression of nephrin, which has been located to the slit diaphragm of glomerular podocytes, where it acts as a renal ultrafilter barrier function. 28 Although the mechanism leading to the downregulation of glomerular nephrin in our rats is not well characterized, the potential role of reactive oxygen species, and particularly, the balance of lipid peroxidase, was recently proposed to account for the decrease in nephrin mRNA in experimental glomerulopathy. 29 Therefore, it is reasonable to consider that IL-10 should directly or indirectly modulate such pathophysiological processes within our obese subjects.
Although the present study provides information regarding the effects of IL-10 on the renal characteristics of the Zucker fa/fa rats, our results should be interpreted within the context of the study's limitations. First, the number of animals included in each group was small, implying that the study may be underpowered for the evaluation of several parameters, and selection bias may also be present. Indeed, our findings, demonstrating that the mean body weights and the food consumption levels of each of the obese groups, might have been underestimated, as it has been reported that IL-10 could attenuate the changes in food intake and energy expenditure in the experimental rat model of acute inflammatory disturbance associated with bacterial infection. 30 It may be interesting to determine whether the IL-10 treatment applied to our obese rats affected their glucose and lipid metabolism without inducing any change in their body weight and food consumption. Whether our findings remain true when the number of subjects is increased should be evaluated in greater detail in a future study.
In summary, AAV vector-mediated IL-10 gene transfer into the Zucker fa/fa rats could introduce efficient and stable IL-10 expression, resulting in the marked reduction of urinary protein excretion. These changes were associated with the recovery of renal structural alterations. Our observations indicate the presence of complex interactions between the changes in the renal characteristics of Zucker fa/fa rats and the inflammatory cascade, as well as the potential benefit of the anti-inflammatory effects of IL-10 in the overall management of glomerulopathy mediated by obesity-related metabolic disorders.
METHODS

AAV vector production
DNA encoding rat IL-10 was PCR-amplified from rat splenocyte complementary DNA as described previously, using the primers 5¢-GCACGAGAGCCAC AACGCa-3¢ and 5¢-GATTTGAGTACGATCCATTTATTCAAAACGAGGAT-3¢. 18 For efficient transgene expression in the skeletal muscle, we constructed a recombinant AAV type 1 vector, which carried the IL-10 gene or GFP gene, controlled by the modified chicken b-actin promoter with the cytomegalovirus posttranscriptional regulatory element (a generous gift from Dr Thomas Hope, Infectious Disease Laboratory, Salk Institute). AAV vectors were prepared according to the previously described three-plasmid transfection adenovirusfree protocol, with minor modification to use the active gassing system. 18, 31 Briefly, 60% confluent human embryonic kidney 293 cells incubated in a large culture vessels were co-transfected with the proviral transgene plasmid, AAV-1 chimeric helper plasmid (p1RepCap), and the adenoviral helper plasmid pAdeno (Avigen Inc., Alameda, CA, USA). 31 The crude viral lysates were purified by two rounds of CsCl in a two-tier centrifugation. The titer of the viral stock was determined against plasmid standards by using dot blot hybridization, after which the stock was diluted in PBS before injection.
Animal model and experimental design
All animal procedures were approved by the Jichi Medical University ethics committee and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Male Zucker-fa/fa and Zucker +/+ rats were obtained from Japan SLC Inc (Shizuoka, Japan). Animals were housed in a temperature and humidity controlled room, and standard rat chow (CE-2, Clea Japan, Inc., Tokyo, Japan) and water were available ad libitum. Five-week-old male Zucker-fa/fa rats were randomly divided into three groups (n¼6 in each group): that is, ZF, ZF+GFP and ZF+IL-10. Control lean littermates administered PBS (ZL) were also included in the study. Under ether anesthesia, the PBS buffer or AAV vectors in PBS were injected into the bilateral anterior tibial muscles of the rats (200 ml per site, 1Â10 11 genome copies per rat). For each animal, body weight and food consumption were measured at 5, 10, 15, 20, 25 and 30 weeks of age. Urinary samples were collected in metabolic sampling bottles over 24 h. Blood samples were collected by tail clipping under ether anesthesia after the rats had fasted for 16 h. In some circumstances, morning blood samples were also collected to determine the fed-state blood glucose and serum immunoreactive insulin levels. The serum levels of Tcho (Cholesterol C-test; Wako Chemicals, Tokyo, Japan), TG (L-Type TG H Kit; Wako Chemicals) and IL-10 (Quantikine ELISA Kit; R&D systems, Minneapolis, MN, USA) were determined according to the manufacturer's instructions. The levels of glucose (Shino-Test, Tokyo, Japan) and HbA1c (RAPIDIA Auto HbA1c-L; Fujirebio, Inc., Tokyo, Japan) were determined with whole blood samples. The immunoreactive serum insulin level was determined using a commercial radioimmunoassay kit (Rat insulin RIA kit; Linco Research, Inc., St Charles, MO, USA) with rat insulin as the standard. Systolic blood pressure was measured by the non-invasive tail-cuff method using a manometer -tachometer system (MK-2000, Muromachi Kikai, Tokyo, Japan). The amount of urinary protein excretion for 24 h was determined with TP-HR II Wako reagent (Wako Chemicals). Serum creatinine and urinary creatinine were measured with the creatinine reagent (Alfresa Pharma Corporation, Osaka, Japan), using an automated analyzer (Hitachi-7180, Hitachi High-Technologies, Tokyo, Japan). We calculated the Ccr using the following equation: Ccr (ml min À1 )¼urinary creatinine (mg dl À1 ) Â urine flow rate (ml min À1 )/serum creatinine (mg dl À1 ).
Light microscopy
At 30 weeks of age, the anesthetized rats were perfused with 100 ml of saline. For evaluation of light microscopic findings, the kidneys were fixed in 10% paraformaldehyde in PBS (pH 7.4) and finally embedded in paraffin, sectioned, and analyzed for histology. Then, 3-mm sections were subjected to periodic acid-Schiff staining. The mean glomerular tuft volume was determined by the Interleukin 10 and obesity-related nephropathy M Ogura et al images from 50 consecutive glomerular cross sections, which were collected for each of the histological sections using an Olympus BX50 light microscope (Olympus, Tokyo, Japan). The area of each glomerular profile was measured manually by tracing the glomerular outline on a computer screen, and the size of each area was calculated by computerized morphometry (Image-Pro plus, Media Cybernetics, Inc., Bethesda, MD, USA). The measurements were performed in a blinded fashion.
Electron microscopy
For transmission electron microscopy, tissues of the left kidneys fixed with 2.5% glutaraldehyde in phosphate buffer (pH 7.4) were postfixed in 2% osmium tetroxide for 2 h at 4 1C. Then, samples were dehydrated in a graded series of ethanol solutions at room temperature, and embedded in Quetol 812 (Nisshin EM Co., Tokyo, Japan). Thin sections of 80 nm were contrasted with 4% uranyl acetate for 15 min and subsequently stained with lead citrate for 5 min at room temperature. Samples were finally examined using a transmission electron microscope (H-7500, Hitachi High-Technologies). The mean width of the GBM was determined by the images of 100 consecutive glomerular sections obtained from two subjects in each group. For scanning electron microscopic examination, small pieces of the kidney cortex were fixed in 2.5% glutaraldehyde in sodium cacodylate buffer (pH 7.4) for 2 h, and subsequently postfixed in 1% osmium tetroxide. Specimens were then dehydrated in a series of ethanols of increasing concentrations, and critical point dried. Once mounted onto specimen holders and desiccated, the samples were sputtercoated with a layer of gold and examined with a S-4300 scanning electron microscope (Hitachi High-Technologies), and images were collected at standard settings.
Immunofluorescent staining
The analysis of nephrin expression in the renal cortex was performed using an immunofluorescence technique. The snap-frozen sections of 3 mm, fixed in 1% formaldehyde and blocked in 5% normal goat serum, were incubated with rabbit anti-nephrin primary antibodies (Immuno-biological Laboratories Co., Ltd., Gunma, Japan) and washed twice with PBS. Subsequently, sections were also incubated with Alexa Fluor 488-conjugated anti-rabbit antibodies (Invitrogen, Carlsbad, CA, USA). Stained sections were examined using a PROVIS AX-80 optical microscope (Olympus). The results were calculated as the intensity of fluorescence within the glomerular tuft by using the Image J 1.42q software package (National Institutes of Mental Health, Bethesda, MD, USA). On average, over 30 randomly selected hilar glomerular tuft crosssections were assessed per rat.
Statistical analysis
The results were expressed as the means±s.d. of the mean. The data were analyzed by an analysis of variance combined with Fisher's protected least significant difference. Differences with Po0.05 were considered to be statistically significant. The correlation test was used to measure the association between two variables, if appropriate.
